BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Eisai Co., Ltd. Expands Venture Investment to Accelerate Drug Discovery Innovation

Eisai Co., Ltd. announced that the company decided to strengthen and continue its venture investment business, which launched in 2019, with the aim of disc...

June 04, 2024 | News

Takara Bio Inc. Launches Large-Scale Viral Vector Manufacturing with Thermo Fisher’s DynaDrive Bioreactors

Thermo Fisher Scientific in Japan is pleased to announce that, as of 22 April 2024, Takara Bio Inc. has begun large-scale viral vector contract manufacturi...

May 30, 2024 | News

Hitachi High-Tech and Roche Extend Partnership for Another Decade

Hitachi High-Tech Corporation ("Hitachi High-Tech") announced that Roche and Hitachi High-Tech have extended their partnership, committing to at least 10...

May 28, 2024 | News

Eisai and nippon medac Launch Metoject® Subcutaneous Injection Pen for Rheumatoid Arthritis in Japan

Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of the medac group, announced the launch of the anti-rheumatic agent "Metoject® Subcut...

May 23, 2024 | News

Dignitana Signs Multi-Year Distribution Agreement with Konica Minolta for Exclusive Distribution of The DigniCap Scalp Cooling System in Japan

Dignitana has signed a new multi-year Distribution Agreement for technology market leader Konica Minolta to be the exclusive provider of The...

May 22, 2024 | News

Fujitsu Develops Advanced AI to Transform Medical Diagnostics with Multimodal Data Integration

Fujitsu announced the development of explainable AI technology that automatically draws on data in multiple formats, including text, images, and nume...

May 13, 2024 | News

GHIT Fund Allocates JPY 1.64 Billion to Combat Malaria and Neglected Tropical Diseases Through Innovative Partnerships

The Global Health Innovative Technology (GHIT) Fund announced a substantial investment of approximately JPY 1.64 billion (USD 10.8 million) dedicated...

May 09, 2024 | News

C₂N Diagnostics Partners with Mediford Corporation to Expand Alzheimer's Research Services in Japan

-C₂N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a part...

April 29, 2024 | News

PRISM BioLab and ONO Pharmaceutical Forge Strategic Collaboration to Advance Oncology Drug Development

PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein int...

April 26, 2024 | News

AGC Biologics Completes Production of VAR2 Pharmaceuticals' Cancer-Targeting Antibodies

AGC Biologics announced the completion of work with VAR2 Pharmaceuticals on the production of the company’s two antibody candidates targeti...

April 25, 2024 | News

AGC Biologics Expands in Yokohama with Advanced Biomanufacturing Hub Featuring Cytiva Technology

New AGC Biologics facility in Yokohama strengthens access to world-class biomanufacturing in Japan, offering mammalian, mRNA and cell therapy ser...

April 23, 2024 | News

WuXi AppTec's Changzhou Facility Gains PMDA Approval, Bolstering Global Expansion Plans

Latest regulatory approval follows on the back of expansion plans announced during DCAT 2024 With peptides, oligos and peptide conjugates continui...

April 22, 2024 | News

Eisai Launches Injectable Fycompa in Japan for Epilepsy Treatment

Eisai Co., Ltd. announcedthat the injection formulation of its in-house discovered antiepileptic drug (AED) Fycompa (perampanel hydrate) for intravenous (I...

April 19, 2024 | News

Bloomage Secures Global Trust with Comprehensive Compliance, Passing Japan's PMDA Audit and Other International Inspections

Bloomage recently successfully completed the on-site Good Manufacturing Practice (GMP) audit conducted by Japan's Pharmaceuticals and M...

April 16, 2024 | Regulatory

Stay Connected